| Name | Title | Contact Details |
|---|---|---|
Chris Szeto |
Chief Product Officer | Profile |
Stacy Corona |
Head Of Supply Chain | Profile |
Jahangir Mohammed |
Founder and Chief Executive Officerv | Profile |
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.
HealthSCOPE Benefits is committed to maintain the exclusive focus of managinghealthcare costs for client companies, to provide unsurpassed customer serviceand seamless benefits administration, managed care, and informatics servicesand to support client
The Avondale Care Group is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Fonix Speech, Inc. is a Lindon, UT-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
MedTrials Inc is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.